Gemcitabine--a major advance?

Ann Oncol. 1998 Dec;9(12):1265-7. doi: 10.1023/a:1008498219576.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / pharmacology
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Clinical Trials as Topic
  • DNA Replication / drug effects
  • DNA, Neoplasm / biosynthesis
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / pharmacology
  • Deoxycytidine / therapeutic use
  • Gemcitabine
  • Humans
  • Lung Neoplasms / drug therapy
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasms / drug therapy*
  • Pancreatic Neoplasms / drug therapy

Substances

  • Antimetabolites, Antineoplastic
  • DNA, Neoplasm
  • Deoxycytidine
  • Gemcitabine